Jupiter NeurosciencesJUNS +1.75%4 Days Payable is 2,034.88 as of Mar. 2026, which is 89% below its 10-year median of 18,706.25. GuruFocus rates JUNS with a GF Score™ of 4/100. The stock has 6 warning signs investors should review. Among 704 Biotechnology companies, Jupiter Neurosciences ranks better than 96.59% on this metric.
Jupiter Neurosciences Days Payable Historical Data
* Premium members only.
The historical data trend for Jupiter Neurosciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Jupiter Neurosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jupiter Neurosciences Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jupiter Neurosciences's Days Payable distribution charts can be found below:
* The bar in red indicates where Jupiter Neurosciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Jupiter Neurosciences's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jupiter Neurosciences (JUNS) has a Days Payable of 2,034.88 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jupiter Neurosciences and its competitors. This is 89% below median its historical median of 18,706.25. Over the past decade, Jupiter Neurosciences' Days Payable has ranged from 17,709.80 to 18,706.25. According to the industry distribution chart, Jupiter Neurosciences ranks #24 out of 704 companies in the Biotechnology industry, placing it in the top 3.4%.
Is Jupiter Neurosciences' Days Payable too high?
Jupiter Neurosciences' current Days Payable of 2,034.88 is 89% below median its 10-year median of 18,706.25. Over the past 10 years, this metric has ranged from a low of 17,709.80 to a high of 18,706.25. The Biotechnology industry median Days Payable is 113.56. Jupiter Neurosciences' value of 2,034.88 is 1691.9% above this industry median. Based on the distribution chart, Jupiter Neurosciences ranks #24 out of 704 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Jupiter Neurosciences has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Jupiter Neurosciences' Days Payable compare to ZEOX and LEXX?
According to the Biotechnology industry distribution chart, Jupiter Neurosciences ranks #24 out of 704 companies for Days Payable. This places Jupiter Neurosciences in the top 3% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.56. Jupiter Neurosciences' value of 2,034.88 is 1691.9% above this benchmark. Historically, Jupiter Neurosciences' own Days Payable has ranged from 17,709.80 to 18,706.25 over the past decade. While the company's 10-year median is 18,706.25 vs. the industry median of 113.56, Jupiter Neurosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jupiter Neurosciences's current Days Payable of 2,034.88 is 1691.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jupiter Neurosciences and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jupiter Neurosciences's current Days Payable is 2,034.88, which is 89% below median its own 10-year median of 18,706.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jupiter Neurosciences stock overvalued right now?
Jupiter Neurosciences (JUNS) has a current Days Payable of 2,034.88. The current Days Payable is 2,034.88, which is 89% below median its 10-year median of 18,706.25 and 1691.9% above the Biotechnology industry median of 113.56. Jupiter Neurosciences' overall GF Score™ is 4/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Jupiter Neurosciences (JUNS), the current Days Payable is 2,034.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform. Its platform product, JOTROL, is an enhanced oral formulation of resveratrol, which has many potential indications. In the larger disease areas, which are targeting Parkinson's Disease. The group is presently in the process of conducting a Phase IIa clinical trial in Parkinson's Disease. The company operates through two reportable segments: premium nutritional supplements and pharmaceutical operations focused on drug candidates for CNS and rare orphan diseases. It generates the majority of its revenue from Premium Nutritional Supplements, which includes commercialization and sales of the Company's Nugevia product line.
4GF Score
Get the complete analysis for JUNS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JUNS has been successfully added to your 
